EmsanaRx, True Choice America and Exponent Health Announce Partnership to Provide Innovative Pharmacy Benefit Management Model

LOUISVILLE, Ky., May 31, 2022 (Newswire.com) - Backed by some of the largest employers in the U.S., pharmacy benefit manager (PBM) EmsanaRx, PBC announced today a partnership with True Choice America, a developer of pharmacy networks for large employers, and Exponent Health, a technology platform providing employers access to advanced analytics that enable them to reduce their drug costs. The three partners share a common goal of reshaping the health care marketplace by providing self-insured employers access to custom national retail pharmacy programs, real-time clinical support and data and by eliminating PBM pricing schemes that lead to rising prescription drug costs. 

EmsanaRx is part of the Emsana Health group of companies launched by the Purchaser Business Group on Health, a non-profit member organization representing the interests of nearly 40 of the country's largest private employers and public health care purchasers. As the only pharmacy benefit manager created by employers, for employers, EmsanaRx designs solutions to serve the needs of patients and those who pay for their care by increasing health care quality and transparency and lowering the drug costs burdening businesses and workers alike. 

With the True Choice America platform, EmsanaRx customers will have unprecedented direct access to pharmacy networks utilized and controlled by large employers across the country. This model eliminates the "spread" pricing prevalent in the PBM industry while increasing savings and clarity into the actual cost of each and every prescription. Independent rebate partner, Exponent Health, will ensure customers maximize savings by harnessing its Expio™ platform. Expio™ utilizes a predictive AI-based technology platform that provides unparalleled transparency into rebate and drug cost pricing, empowering employers to make informed decisions about the formularies included in their prescription drug benefits while optimizing rebate value. EmsanaRx's strategic selection of these partners ensures its clients have the most advanced, unbiased approach to managing their pharmacy benefits. 

"This partnership will help us improve how effectively we serve our employer clients. True Choice and Exponent Health have proven solutions that allow large employers to ensure access to the medications employees and their families need while managing costs by delivering actionable data and analytics," said Greg Baker, CEO of EmsanaRx. "Collaboration between like-minded health care cost management platforms and PBMs can further transform the way we provide care. Our partnerships across the care continuum will empower critical decision-makers at the point of sale to help improve medication adherence and reduce avoidable medical costs."

"True Choice America is committed to supporting plan sponsors and bridging the knowledge gap between retail pharmacies and these employers. These levels of transparency are rarely seen and ultimately provide a higher quality of care at a lower cost to members," said Kevin Hooks, CEO of True Choice America. "This collaborative approach to pharmacy management will improve the transparency and quality of care, while reducing unnecessary medical costs for millions of people."

"At Exponent Health, we are powering future health care cost management and are excited to work with partners that are also pushing the industry forward. Our Expio platform leverages industry and rebate data to unlock full savings potential. Combining that with the capabilities of EmsanaRx and True Choice America will create a highly effective, next-generation solution for making pharmacy more affordable," said Karin Humphrey, CEO of Exponent Health.

About True Choice America

True Choice America was created to provide complete access to and control of the pharmacy networks utilized by large employers across the country. This methodology has eliminated the "spread" pricing prevalent in the PBM industry and provides a window into the actual cost of every prescription. This benefits employers by removing unknowns and increasing savings. Learn more at TrueChoiceAmerica.com.

About Exponent Health, formerly HRGi

For over 30 years, Exponent Health, formerly HRGi, has been evolving cost management and revenue optimization across health care - from large, national payors and Blues plans, to PBMs and TPAs. As a technology company dedicated to health care cost reduction, Exponent Health's innovative Expio™ platform powers a suite of solutions that provide decision support for complex cost management challenges - giving clients a new and better way to manage pharmacy rebates, out-of-network medical claims repricing and negotiations, and much more. All supported by best-in-class operations and the highest security and compliance standards, including HITRUST certification. Learn more at: www.ExponentHealth.com or connect with us on LinkedIn.

About EmsanaRx

EmsanaRx is part of the Emsana Health group of companies which is majority owned by the Purchaser Business Group on Health (PBGH). PBGH is a non-profit coalition of nearly 40 large, private employers and public health care purchasers committed to transforming health care nationwide. EmsanaRx envisions a clinically focused, patient-centric pharmacy benefit industry. Our mission is to improve health care outcomes by bringing clarity, integrity and trust to pharmacy benefit management. We partner with self-insured employers to deliver patient-centric pharmacy benefits. Learn more at www.emsanaRx.com. Connect with us on LinkedIn at www.linkedin.com/company/emsanaRx

Source: EmsanaRx, PBC